FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid

FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid

AstraZeneca contacted Gilead last month and it did not provide terms of any transaction, the report added.

  • Reuters
  • Last Updated: June 7, 2020, 2:44 PM IST

Share this:

AstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc about a potential merger, Bloomberg News reported on Sunday, citing people familiar with the matter.

AstraZeneca contacted Gilead last month and it did not provide terms of any transaction, the report added.

The two companies were not immediately available for comment.

Details awaited.


Share this:

Next Story

Read More

WP2Social Auto Publish Powered By : XYZScripts.com
Scroll Up